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ABSTRACT  25 
To test the hypothesis that in domestic cats, postnatal androgens induce sterility, the 26 
aims of this study were to describe the reproductive effects and the clinical safety of a 27 
postnatal administration of a long term release androgen in this species. Thirteen newborn 28 
littermate female kittens were randomly assigned to one of the following treatment groups 29 
within the first 24 hours of birth: testosterone enanthate 12.5 mg sc (TE; n = 8) or Placebo 30 
(PL; n = 5). The animals were subsequently assessed for fecal sexual hormones until 31 
puberty was attained and subsequently when matings occurred. After 21 days, ovulation 32 
and gestation were diagnosed. All queens were subsequently ovario-hysterectomized. Fecal 33 
testosterone concentrations differed between the treatment groups throughout the study 34 
period (P < 0.05) being greater during the first 2 postnatal weeks in those of the TE group 35 
(P < 0.01). Fecal estradiol was not affected by treatment (P > 0.1). While all the females 36 
were receptive during the pubertal estrus (P> 0.1), two TE (2/8) compared with all (5/5) 37 
females of the PL group had ovulations (P < 0.05). Only one (1/2) compared with three 38 
(3/5) of the queens of the TE and PL groups, respectively became pregnant.  All kittens of 39 
the TE group had transient clitoral enlargement. Anovulatory TE-treated cats had no corpus 40 
luteum, and a significant diminution of the endometrial glands as well as of the height of 41 
the uterine epithelium. It is concluded that, in domestic cats, a single postnatal supra-42 
physiological dose of testosterone caused a large proportion of queens to be anovulatory 43 
and there were also histological endometrial abnormalities that also occurred with this 44 
treatment that were accompanied by mild and transient side effects.  45 
 46 





1. Introduction 50 
Domestic cat (Felis catus) overpopulation is an insurmountable problem in almost all 51 
the countries of the world. Female cats are extremely prolific breeders and can reproduce 52 
from early puberty (e.g. 4 month) until death (Johnston et al., 2001). Furthermore, from the 53 
equator to areas with temperate photoperiods domestic felids breed throughout the year 54 
(Faya et al., 2011). In developing countries, unwanted kittens are simply abandoned to 55 
suffer and die on the streets being problematic to both the animals themselves and humans. 56 
Safe, efficient and practical pharmaceutical protocols are still needed to manage the feline 57 
overpopulation problem.  58 
Sex steroids have organizational actions during late gestation and early postnatal life in 59 
both altricial and precocial species such as mice, rats and sheep (Jackson et al., 2013).  60 
Specifically, during the early postnatal period the developing central nervous system is 61 
sensitive to the organizing effects of androgens. In this respect, both genders normally 62 
differ in pattern of pituitary gonadotropin secretion and the male non-cyclic pattern of 63 
gonadotropin secretion is induced by the action of testicular androgens on the anterior 64 
hypothalamus during the postnatal period (Jackson et al. 2013).  65 
In female rats, there exists a critical postnatal period when there is greater tissue 66 
differentiation sensitivity during which a single androgen administration permanently alters 67 
both the hypothalamic mechanisms which underlie “cyclic” gonadotropin release patterns 68 
and the target tissue response to estrogens (Gorski, 1971; Harris, 1970; Lobl et at., 1975, 69 
Lobl and Gorski, 1974, Mena et al., 1992). Androgenization of developmental tissues in 70 
neonatal pigs also resulted in anovulatory infertility (Ventanas et at., 1992). As a result, 71 
androgenized females are anovulatory, anestrous, and have altered uterine morphology and 72 
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function as well as greater male behavioral expression than untreated females (Barraclough 73 
and Gorski, 1961; Lobl and Maenza, 1977). When female dogs were injected postnatally 74 
with an androgen for 3 months, there was delayed puberty, anovulatory syndrome and 75 
complete lack of receptivity to males (Beach et al., 1983). Furthermore, rats injected on the 76 
first days of life with testosterone had ovarian atrophy (Pinilla et al., 1993).  77 
Thus, androgen treatment early in life prevents ovulation as well as normal uterine 78 
function and sexual behavior and may have implications for development of this 79 
methodology as a contraceptive strategy for felids. To the best of the authors´ knowledge 80 
the effect of postnatal androgenization has never been assessed in domestic cats. 81 
To test the hypothesis that in domestic cats, similar to other mammals (Barraclough and 82 
Gorski, 1961; Beach et al., 1983; Ventanas et at., 1992) exogenous androgens induce 83 
sterility if administered during the postnatal critical reproductive developmental period, the 84 
aims of the present study were to describe the clinical and histological reproductive effects 85 
of the postnatal administration of an androgen. Secondly, the clinical safety of the treatment 86 
was also assessed. For this purpose, testosterone enanthate, a potent, long term effective 87 
androgen (Plumb, 2015) which is inexpensive and available worldwide was selected as the 88 
endocrine disruptor for this experiment.  89 
 90 
 91 
2. Materials and methods  92 
2.2. Animals and pharmacological protocols 93 
Thirteen (five litters) newborn littermate female kittens from the National 94 
University of La Plata institutional cat colony were included in this study.  The animals 95 
were sexed according to anogenital distance and identified at birth, reared under 14 hours 96 
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of light per day, weaned at the age of 40 days and fed premium commercial food and water 97 
ad libitum. This study was reviewed and approved by the Animal Care and Use Committee 98 
of the Veterinary School of the National University of La Plata and all experiments were 99 
conducted under the guidelines established in The Guide for The Care and Use of 100 
Laboratory Animals, USA. 101 
The kittens of the same litters were randomly assigned to one of the following 102 
treatment groups within the first 24 hours of birth: Testosterone enanthate 12.5 mg total 103 
dose  (Testoviron Depot 250, Bayer, Argentina) subcutaneously (TE; n = 8) or Placebo: 104 
0.05 ml corn oil subcutaneously injection (PL; n = 5). The dose was selected according to 105 
previous pilot studies in cats based on a classical animal model (Barraclough and Gorski, 106 
1961). 107 
 108 
2.3. Physiological and anatomical assessments 109 
All the animals were subsequently assessed for specific anatomical, behavioral, and 110 
physiological characteristics until the first indications of puberty occurred. During this 111 
assessment period, the animals were observed 1.5 hours twice a day for evaluating sexual 112 
behavior and were physically examined and weighed once a week. Eventual appearance of 113 
clinical side effects was also recoded. Vaginal cytology (Mills et al., 1979) assessments 114 
were conducted three times per week after the third month of age. Puberty was defined by 115 
the finding of more than 80% superficial keratinized cells and a clean background in the 116 
vaginal smears accompanied by the typical estrous behavior (Johnston et al., 2001). 117 
 118 
2.4. Fecal collection, extraction and hormone determinations  119 
6 
 
Fecal samples were collected weekly until the time of puberty and frozen for 120 
testosterone (T) and estradiol-17β (E2) determinations. Fecal collection was initiated at the 121 
end of the first postnatal week. For this purpose, each cat was confined in an individual 122 
cage with clean sanitary litter one night per week. During the first 4 weeks of age, the 123 
neonates had to be rectally stimulated by a thin plastic suppository attached to a string to 124 
obtain the sample. Fecal steroids were extracted using the methods described by Brown et 125 
al. (2008) and T (ng/ml) and E2 (pg/ml) were determined using electrochemiluminescence 126 
immunoassays (Elecsys Testo II and Estradiol II, Roche Diagnostics, Mannheim, 127 
Germany). Inter- and intra-assay coefficients of variation of the assays were <10% and 128 
sensitivity were 0.025 ng/mL and 12 pg/mL for T and E2 kits, respectively. All fecal data 129 
were expressed on a wet-weight basis (Faya et al., 2013). 130 
 131 
2.5. In vivo fertility test, ovulation and pregnancy diagnosis 132 
As the female cats attained puberty, there was exposure to a fertile tomcat during the 133 
estrous period. Matings were observed and/or diagnosed by the presence of spermatozoa in 134 
the vaginal smears. Twenty-one days after the end of estrus, blood samples were taken for 135 
ovulation assessment by electrochemiluminescence immunoassay determination of serum 136 
progesterone (Elecsys Progesterone II, Roche Diagnostics, Mannheim, Germany; P4 > 5 137 
ng/mL) and gestation was diagnosed by ultrasonic examination in all the females (Mattoon 138 
and Nyland, 1995). 139 
 140 
2.6. Ovariohysterectomies  141 
Following assessments for pregnancy status, all queens were ovariohysterectomized and 142 
the ovaries and uteri were subjected to histological study. For the surgery, the animals were 143 
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pre-medicated with atropine sulfate, (Atropine Sulfate, John Martin; 0.04 mg/kg, 144 
subcutaneously), acepromazine maleate (Acedan, Holiday; 0.03 mg/ kg subcutaneously), 145 
and butorphanol (Torbutol Plus, Fort Dodge; 0.2 mg/kg, intramuscularly). Anesthesia was 146 
induced with sodium thiopental (Pentovet TM, Richmond; 8 mg/kg, intravenous). After the 147 
females were endotracheally intubated, anesthesia was maintained with isoflurane and 148 
oxygen in a closed system. A mid-line laparotomy was performed to excise the ovaries and 149 
uteri (Arnold, 2002). After surgery ketoprofen (Ketofen®, Fort Dodge; 1 mg/kg) was 150 
injected subcutaneously (once) and then orally every 24 hours for 4 additional days. All the 151 
queens were then placed for adoption. 152 
 153 
2.7.Gross and histomorphometrical examination 154 
 155 
Immediately after surgery genital tracks were excised and ovaries and uteri were 156 
macroscopically examined and weighed. The ovaries were sectioned longitudinally, placed 157 
in Bouin’s fixative for 12 h and placed in 70% alcohol and processed routinely with 158 
paraffin embedding.  After processing, 5 µm serial sections were cut, mounted on slides, 159 
dyed, deparaffinized in xylene, rehydrated in graded ethanol solutions and stained with 160 
hematoxylin and eosin.  161 
Follicles were classified as primordial (small oocyte surrounded by a single layer of 162 
squamous granulosa cells), primary (oocyte surrounded by a single layer of cuboidal cells), 163 
secondary (two or more layers of granulosa cells and a theca cell layer), antral (fluid-filled 164 
antrum, mural and cumulus granulosa cells and two or more layers of thecal cells) or atretic 165 
(degenerated granulosa cells and follicular fluid containing cellular debris as previously 166 
described; Bristol-Gould and Woodruff, 2006). The number of primordial, primary, 167 
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secondary and antral follicles, corpora lutea, and atretic follicles per square millimeter was 168 
determined on a computer screen using 20 captured images (X20) per animal obtained from 169 
two, 3 mm- sections.  170 
Uteri were sectioned longitudinally for internal inspection. Cross-sections 171 
(approximately 0.5-1 cm) were collected from a point midway between the external 172 
bifurcation and the tip of each uterine horn and processed as described for the ovaries. The 173 
uteri were examined for the presence or absence of endometrial glands. The area occupied 174 
by uterine glands per mm
2
 of endometrium over the total area of each microscope field was 175 
measured by planimetry. The height of the glandular and luminal uterine epithelium was 176 
assessed counting 100 cells in a total of 10 images per uterus taken with a 10X objective 177 
while myometrial thickness was examined in a total of four images per uterus taken with a 178 
4X objective.  179 
All histological images were obtained from a microscope (Olympus BX50, Tokyo, 180 
Japan; 10X through an attached digital RGB video camera (Evolution VF Color, Q 181 
Imaging, USA) and digitalized in a 24 bit true color TIFF format. These images were 182 
analyzed using Image Pro Plus v6.0-Media Cybernetics (Silver Spring, MA, USA). 183 
 184 
2.8. Statistical analysis 185 
Quantitative and qualitative differences between TE and PL groups were conducted by 186 
Fisher Exact and Student´s t tests, respectively. Fecal T and E2 concentrations were 187 
analyzed by repeated measures ANOVA followed by Tukey comparison test. Data were 188 
expressed as (mean ±SEM) and the level of significance was set at P < 0.05 (SPSS 17.0, 189 




3. Results 192 
Age (34 ± 2.6 compared with 33.0 ± 2.3 weeks; P>0.1) and body weight (2.92 ± 0.7 193 
compared with 2.76 ± 0.9 kg; P>0.1) at puberty attainment did not differ between TE and 194 
PL groups. Fecal T concentrations differed between the treatments throughout the weeks of 195 
the study (P < 0.05) being greater in the TE than in PL groups during the first 2 postnatal 196 
weeks (P < 0.01; Fig. 1A). Conversely, fecal E2-17β concentrations varied during the study 197 
without differences between treatments (P > 0.1). Thus, in both groups, E2 was elevated 198 
during the first 5 postnatal weeks (P < 0.01). The E2 remained basal until 3 to 4 weeks 199 
before puberty when concentrations began to increase (Fig. 1B). 200 
All TE-treated kittens had vulva and clitoris enlargement during postnatal weeks 3 to 13 201 
and were of typical developmental size, thereafter.  There was also one case (1/8) of 202 
transient mammary nodules in an animal of the TE-treatment group. In this case two 1.8 cm 203 
diameter nodules appeared in the pectoral and inguinal left mammary glands on week 27 204 
and gradually decreased in size to week 39 at the time of spaying.  205 
One kitten of the TE group displayed mounting behavior  preceding puberty.  All the 206 
females had normal estrous behavior, were receptive to males (P > 0.1) and were, therefore, 207 
repeatedly mated during the pubertal estrus. While all the cats of the PL group (5/5) had 208 
ovulations and three were pregnant when assessments occurred, ovulation occurred in two 209 
of eight females of the TE group (P < 0.05) and one of the females was pregnant at the time 210 
of assessment. In both groups, gestations progressed normally until the time of 211 
ovariohysterectomies when the examination of the excised uteri revealed four to five 212 
conceptuses. 213 
Ovarian weight did not differ between animals in the TE and PL  (0.17 ± 0.0 compared 214 
with 0.16 ± 0.0 g; P > 0.1) groups. Gross ovarian examination revealed follicles and 215 
10 
 
corpora lutea in the animals that failed to and those that had ovulations, respectively. No 216 
further gross nor microscopical differences were detected between treatment groups for the 217 
ovarian variables that were studied  (Table 1).  218 
Gross external and internal uterine observations were normal in all but one queen in the 219 
TE group which was in estrus again at the time of surgery and had generalized abdominal 220 
hyperemia and a slightly increased bleeding. In this queen the entirety of the uterine horns 221 
and endometrium were also thicker than in the other cats.   222 
Microscopic assessment of the uteri revealed that the area occupied by uterine glands 223 
per mm
2
 of endometrium was smaller in the TE than in the PL group (0.34 ± 0.01 224 
compared with 0.49 ± 0.03; P < 0.01). Conversely, the area occupied by stroma per mm
2
 225 
was larger in the TE queens (0.64 ± 0.01 compared with 0.50 ±0.03; P < 0.01). The height 226 
of the glandular (m; 13.89 ± 0.29 compared with 21.43 ±1.10; P < 0.01) and luminal (m; 227 
8.09 ± 0.39 compared with 9.44 ± 0.42; P < 0.05) uterine epithelium were shorter in the TE 228 
than in the PL group (Fig. 2).  Myometrial thickness did not differ between the two groups 229 
(m; 286.43 ± 8.23 vs. 298.36+8.62; P < 0.05).  230 
 231 
4. Discussion 232 
Although, postnatal androgenization effects have been reported in several mammalian 233 
species including dogs (Barraclough and Gorski, 1961; Beach et al., 1983; Jackson et al., 234 
2013; Lobl and Gorski, 1974; Ventanas et al., 1992), to the authors' knowledge, this is the 235 
first study that describes the effect of a single postnatal supra-physiological dose of a 236 
potent, time-released androgen on female cat reproduction. In the kittens of the present 237 
study, androgen treatment did not alter growth rate, age at puberty attainment nor estrous 238 
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behavior and receptivity. Similarly, in postnatally androgenized rats, body weight did not 239 
differ from that of control animals (Almirón et at., 1984).  240 
It is generally accepted that testosterone, when present for a period after birth, can 241 
permanently suppress development of female reproductive behavior but this premise is not 242 
consistent with findings in a previous study where sexual receptivity was not affected by 243 
testosterone treatment of female pigs early in life (Ford and Christenson, 1987). 244 
Conversely, normal sexual behavior was abolished in neonatally-androgenized rodents and 245 
bitches (Beach et al. 1983, Gogan et al. 1980, Thomas et al. 1983). These inconsistencies in 246 
results may be due to dose and species differences in the behavioral response to postnatal 247 
testosterone.  248 
The increased fecal T during the first 2 postnatal weeks in the kittens of the TE group in 249 
the present study clearly indicates the exogenous effects of the hormonal treatment on 250 
anatomical and behavioral characteristics in cats and defines the time period of the “the 251 
critical period” to permanently differentiate sexual reproductive function in this species. 252 
Conversely, fecal E2 does not seem to be affected by androgen treatment. Furthermore, the 253 
augmented E2 concentrations during the first 5 postnatal weeks could be due to an 254 
endogenous origin (Faya et al., 2013). 255 
The transient vulvar and clitoris abnormalities and the mounting behavior observed in 256 
all and one the TE-treated cats, respectively, are evidence of the peripheral effects of 257 
testosterone. Furthermore, these changes were expected according to previous reports in 258 
other postnatally androgenized species (Brown et al., 1999, Morali et al., 1985).  259 
Consistent with findings in the present study with what has been extensively described 260 
for other mammals (Jackson et al., 2013), the hypothalamic-pituitary-ovarian axis 261 
functionality was probably affected in most of these queens as 75% of the TE-treated 262 
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animals were anovulatory. It is assumed that anovulation resulted from an androgen-263 
induced disorder of the postnatal hypothalamus and the subsequent change in the release 264 
pattern of luteinizing hormone from the pituitary gland (Barraclough, 1961; Wagner et al., 265 
1966). This supports the hypothesis that the hypothalamus is sensitive, at least in part, to 266 
programming by postnatal steroids in this altricial species. Both the absence of luteal tissue 267 
and ovarian abnormalities in the testosterone-treated cats that were anovulatory suggest the 268 
central origin of the infertility in these cats. It could also be possible that postnatal 269 
testosterone might alter target tissue receptor sensitivity and, therefore, response to 270 
hormones.  271 
Similarly to what has been described for other endocrine disruptors in postnatal cats 272 
(Carranza et al., 2014), differences in individual response may have also accounted for the 273 
findings in the present study. It is worth noting that a dose effect has been previously 274 
described for aromatizable and non-aromatizable androgens in the induction of anovulatory 275 
syndrome in rats (Arai et al., 1981, Gorski and Barraclough, 1963). Although a larger 276 
testosterone dose may have decreased or eliminated the variability of anovulation in the 277 
present study, the possibility of use of a larger dose for this purpose does not appear to be 278 
feasible as there would likely be an increase in the prevalence and severity of side effects. 279 
The follicles from which ovulation did not occur might have functioned to increase 280 
estrogens in the bloodstream and may have led to the notable inflammation, hemorrhages, 281 
and hyperplasia in the endometrium in the testosterone-treated queen of the present study 282 
which was spayed while in estrus. These abdominal findings were similar, in some aspects 283 
to those described for human ovarian hyper-stimulation syndrome which is characterized 284 
by multiple ovarian cysts and subsequent hyper-esterogenemia (Jones et al., 1987). 285 
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The mammary nodules in the TE-group of the present study were not histologically 286 
examined and the transient existence suggests a non-neoplastic etiology. Similarly, 287 
postnatal dihydrotestosterone treatment resulted in the stimulation of mammary 288 
development at advanced ages in female mice (Yanai et al., 1981). Importantly, it should 289 
also be taken into account that the eventual long term undesired effects should not be 290 
discarded for the treatments used in the present study as these were not studied in the time 291 
frame of present trial. 292 
Postnatal testosterone treatment, in the felids of the present study, reduced 293 
the area occupied by endometrial glands and cell development in both glandular and 294 
luminal epithelial tissues. Similar findings have been described in postnatal 295 
androgenized rats (Arutiunian et al., 1987) and also in progesterone-treated postnatal 296 
dogs (Wilborn et al., 2014). As normal endometrial glands are required for establishment 297 
and maintenance of pregnancy the question about a concomitant uterine infertility arises 298 
and remains to be unveiled in most of these anovulated testosterone treated females. 299 
Normal uterine functionality could only be ascertained in the pregnant androgenized female 300 
of the present study. Inconsistent with what has been found in postnatal androgenized rats 301 
(Lobl and Maenza, 1977), no variations in myometrium thickness was found in the present 302 
feline study.  303 
It is concluded that a single postnatal supra-physiological dose of testosterone 304 
enanthate caused a large proportion of queens to be infertile due to anovulation and 305 
histological endometrial abnormalities were prevalent in these cats.  Furthermore, this 306 
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pharmacological protocol seemed to predispose queens to mild reversible physical side 307 
effects. More knowledge is necessary before these pharmacological protocols could be 308 
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Figure legends 419 
 420 
Fig. 1.  Fecal testosterone (A; P < 0.05) and estradiol-17β (B; P >0.1) concentrations (mean 421 
± SEM) of 13 female kittens treated postnatally with testosterone enanthate 12.5mg (solid 422 
symbols) or a placebo (open symbols) and subsequently assessed until the first pubertal 423 
signs appeared for anatomical and behaviorally characteristics; Asteriks over the symbols 424 
indicate selected differences (P < 0.01) between groups 425 
 426 
Fig. 2. Ovaries (hematoxylin and eosin, 4X) of female cats; Animals treated with 427 
testosterone enanthate (A) or placebo (B);   No significant differences (P > 0.05) were 428 
detected between groups for any ovarian structure except for the presence of luteal cells 429 
(LC) in the testosterone- treated cats 430 
 431 
Fig 3. Uteri (hematoxylin and eosin, 4X and 20X) of 13 female cats; Animals treated with 432 
testosterone enanthate (A and A´) or placebo (B and B´); Notice fewer (P <0.01) 433 
endometrial uterine glands in the testosterone-treated cats (A and A´) 434 




Table 1. Ovarian gross and histologic variables  (mean + SD) of female cats; No 437 
differences (P > 0.05) were detected between groups  438 
Parameter TE Placebo 
Length (cm) 1.02 + 0.0 0.95+ 0.0 
Height (cm) 0.58 + 0.0 0.65 + 0.0 
Weight (g) 0.16 + 0.0  0.17 + 0.0 
Volume (cm
3
) 0.17 + 0.0 0.20 + 0.0 
Primordial follicles/mm
2 
35.13 + 15.0 38.67 + 7.7 
Primary follicles/mm
2
 6.80 + 1.4 10.62 + 1.8 
Secondary follicles/mm
2
 0.95 + 0.2  1.91 + 0.7 
Antral follicles/mm
2
 0.24 + 0.0 0.08 + 0.0 
Atretic follicles/mm
2 
3.80 + 0.6 3.64 + 0.7  
 439 
 440 
 441 
 442 
 443 
 444 
 445 
 446 
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